Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression

Journal of Affective Disorders

Volumn 119, Issue 1-3, 2009, Pages 132-141

  Alexopoulos, George S ^a   Murphy, Christopher F ^a   Gunning Dixon, Faith M ^a   Glatt, Charles E ^a   Latoussakis, Vassilios ^a   Kelly Jr , Robert E ^a   Kanellopoulos, Dora ^a   Klimstra, Sibel ^a   Lim, Kelvin O ^d   Young, Robert C ^a   Hoptman, Matthew J ^b,c  

^a The Cornell Institute of Geriatric Psychiatry   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Geriatric depression; Serotonin transporter; White matter abnormalities

Indexed keywords

ESCITALOPRAM; SEROTONIN TRANSPORTER;

AGED; ALLELE; ANISOTROPY; ARTICLE; BRAIN REGION; CAUCASIAN; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FOLLOW UP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GERIATRICS; HAMILTON SCALE; HOMOZYGOTE; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; REMISSION; THALAMUS; WHITE MATTER;

AGED; ANISOTROPY; BRAIN; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DIFFUSION TENSOR IMAGING; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POLYMORPHISM, GENETIC; REMISSION INDUCTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 70349769488     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.03.004     Document Type: Article

References (65)

1. Abdelmalik N., Ruhe H.G., Barwari K., Van Den Dool E.J., Meijers J.C., Middeldorp S., Buller H.R., Schene A.H., and Kamphuisen P.W. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J. Thromb. Haemost. 6 (2008) 2168-2174
2. Alessandro S., and Kato M. The serotonin transporter gene and effectiveness of SSRIs. Expert. Rev. Neurother. 8 (2008) 111-120
3. Alexopoulos G.S. Depression in the elderly. Lancet 365 (2005) 1961-1970
4. Alexopoulos G.S., Kiosses D.N., Choi S.J., Murphy C.F., and Lim K.O. Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am. J. Psychiatry 159 (2002) 1929-1932
5. Alexopoulos G.S., Murphy C.F., Gunning-Dixon F.M., Latoussakis V., Kanellopoulos D., Klimstra S., Lim K.O., and Hoptman M.J. Microstructural white matter abnormalities and remission of geriatric depression. Am. J. Psychiatry 165 (2008) 238-244
6. Ardekani B.A., Bappal A., D'angelo D., Ashtari M., Lencz T., Szeszko P.R., Butler P.D., Javitt D.C., Lim K.O., Hrabe J., Nierenberg J., Branch C.A., and Hoptman M.J. Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia. Neuroreport 16 (2005) 1455-1459
7. Arias B., Catalan R., Gasto C., Gutierrez B., and Fananas L. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J. Clin. Psychopharmacol. 23 (2003) 563-567
8. Baudewig J., Dechent P., Merboldt K.D., and Frahm J. Thresholding in correlation analyses of magnetic resonance functional neuroimaging. Magn. Reson. Imaging 21 (2003) 1121-1130
9. Benjamini Y., Drai D., Elmer G., Kafkafi N., and Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125 (2001) 279-284
10. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., Mcclay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
11. Comings D.E., Macmurray J.P., Gonzalez N., Ferry L., and Peters W.R. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol. Genet. Metab. 67 (1999) 248-253
12. Cushman M., Cantrell R.A., Mcclure L.A., Howard G., Prineas R.J., Moy C.S., Temple E.M., and Howard V.J. Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann. Neurol. 64 (2008) 507-513
13. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 48 (2000) 813-829
14. Epping-Jordan Ja Ü.T. The WHODAS-II: leveling the playing field for all disorders. WHO Mental Health Bulletin 6 (2000) 5-6
15. Folstein M.F., Folstein S.E., and Mchugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
16. Goldapple K., Segal Z., Garson C., Lau M., Bieling P., Kennedy S., and Mayberg H. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch. Gen. Psychiatry 61 (2004) 34-41
17. Gould E. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 21 (1999) 46S-51S
18. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., and Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 88 (1999) 83-87
19. Gunning-Dixon F.M., Hoptman M.J., Lim K.O., Murphy C.F., Klimstra S., Latoussakis V., Majcher-Tascio M., Hrabe J., Ardekani B.A., and Alexopoulos G.S. Macromolecular white matter abnormalities in geriatric depression: a magnetization transfer imaging study. Am. J. Geriatr. Psychiatry 16 (2008) 255-262
20. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
21. Hariri A.R., Drabant E.M., and Weinberger D.R. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol. Psychiatry 59 (2006) 888-897
22. Hickie I.B., Naismith S.L., Ward P.B., Scott E.M., Mitchell P.B., Schofield P.R., Scimone A., Wilhelm K., and Parker G. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J. Affect. Disord. 98 (2007) 137-142
23. Horsfield M.A., and Jones D.K. Applications of diffusion-weighted and diffusion tensor MRI to white matter diseases - a review. NMR Biomed. 15 (2002) 570-577
24. Hu X., Oroszi G., Chun J., Smith T.L., Goldman D., and Schuckit M.A. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol. Clin. Exp. Res. 29 (2005) 8-16
25. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., and Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 78 (2006) 815-826
26. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., Paulus M.P., Kunovac J.L., Leon A.C., Mueller T.I., Rice J.A., and Keller M.B. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J. Affect. Disord. 50 (1998) 97-108
27. Kochunov P., Thompson P.M., Lancaster J.L., Bartzokis G., Smith S., Coyle T., Royall D.R., Laird A., and Fox P.T. Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. Neuroimage 35 (2007) 478-487
28. Kraft J.B., Peters E.J., Slager S.L., Jenkins G.D., Reinalda M.S., Mcgrath P.J., and Hamilton S.P. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol. Psychiatry 61 (2007) 734-742
29. Kumar A., Gupta R.C., Albert Thomas M., Alger J., Wyckoff N., and Hwang S. Biophysical changes in normal-appearing white matter and subcortical nuclei in late-life major depression detected using magnetization transfer. Psychiatry Res. 130 (2004) 131-140
30. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
31. Lotrich F.E., Pollock B.G., and Ferrell R.E. Serotonin transporter promoter polymorphism in African Americans: allele frequencies and implications for treatment. Am. J. Pharmacogenomics 3 (2003) 145-147
32. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21 (1999) 99S-105S
33. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., Silva J.A., Mcginnis S., Glass T.G., Martin C.C., and Fox P.T. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8 (1997) 1057-1061
34. Mayberg H.S., Liotti M., Brannan S.K., Mcginnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., and Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156 (1999) 675-682
35. Mazziotta J.C., Toga A.W., Evans A., Fox P., and Lancaster J. A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage 2 (1995) 89-101
36. Munafo M.R., Brown S.M., and Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol. Psychiatry 63 (2008) 852-857
37. Murphy D.L., Fox M.A., Timpano K.R., Moya P.R., Ren-Patterson R., Andrews A.M., Holmes A., Lesch K.P., and Wendland J.R. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 55 (2008) 932-960
38. Nakamura M., Ueno S., Sano A., and Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 5 (2000) 32-38
39. Nakatani D., Sato H., Sakata Y., Shiotani I., Kinjo K., Mizuno H., Shimizu M., Ito H., Koretsune Y., Hirayama A., and Hori M. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am. Heart J. 150 (2005) 652-658
40. Nobler M.S., Oquendo M.A., Kegeles L.S., Malone K.M., Campbell C.C., Sackeim H.A., and Mann J.J. Decreased regional brain metabolism after ECT. Am. J. Psychiatry 158 (2001) 305-308
41. Nobuhara K., Okugawa G., Sugimoto T., Minami T., Tamagaki C., Takase K., Saito Y., Sawada S., and Kinoshita T. Frontal white matter anisotropy and symptom severity of late-life depression: a magnetic resonance diffusion tensor imaging study. J. Neurol. Neurosurg. Psychiatry 77 (2006) 120-122
42. Ogilvie A.D., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwim G.M., and Smith C.A. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347 (1996) 731-733
43. O'hara R., Schroder C.M., Mahadevan R., Schatzberg A.F., Lindley S., Fox S., Weiner M., Kraemer H.C., Noda A., Lin X., Gray H.L., and Hallmayer J.F. Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol. Psychiatry 12 (2007) 544-555
44. Parsey R.V., Hastings R.S., Oquendo M.A., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., and Mann J.J. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am. J. Psychiatry 163 (2006) 52-58
45. Patankar T.F., Baldwin R., Mitra D., Jeffries S., Sutcliffe C., Burns A., and Jackson A. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. J. Affect. Disord. 97 (2007) 265-270
46. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., and Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulated-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 8 (2005) 828-834
47. Pollock B.G., Ferrell R.E., Mulsant B.H., Mazumdar S., Miller M., Sweet R.A., Davis S., Kirshner M.A., Houck P.R., Stack J.A., Reynolds C.F., and Kupfer D.J. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23 (2000) 587-590
48. Pollock B.G., Laghrissi-Thode F., and Wagner W.R. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J. Clin. Psychopharmacol. 20 (2000) 137-140
49. Reist C., Mazzanti C., Vu R., Tran D., and Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am. J. Med. Genet. 105 (2001) 363-368
50. Robinson R.G., Jorge R.E., Moser D.J., Acion L., Solodkin A., Small S.L., Fonzetti P., Hegel M., and Arndt S. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 299 (2008) 2391-2400
51. Salloway S., Boyle P.A., Correia S., Malloy P.F., Cahn-Weiner D.A., Schneider L., Krishnan K.R., and Nakra R. The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am. J. Geriatr. Psychiatry 10 (2002) 107-111
52. Simpson S., Baldwin R.C., Jackson A., and Burns A.S. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol. Med. 28 (1998) 1015-1026
53. Smith G.S., Reynolds III C.F., Pollock B., Derbyshire S., Nofzinger E., Dew M.A., Houck P.R., Milko D., Meltzer C.C., and Kupfer D.J. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am. J. Psychiatry 156 (1999) 683-689
54. Smith G.S., Kramer E., Hermann C.R., Goldberg S., Ma Y., Dhawan V., Barnes A., Chaly T., Belakhleff A., Laghrissi-Thode F., Greenwald B., Eidelberg D., and Pollock B.G. Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am. J. Geriatr. Psychiatry 10 (2002) 715-723
55. Smith G.S., Lotrich F.E., Malhotra A.K., Lee A.T., Ma Y., Kramer E., Gregersen P.K., Eidelberg D., and Pollock B.G. Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 29 (2004) 2226-2234
56. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., and Behrens T.E. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31 (2006) 1487-1505
57. Solai L.K., Mulsant B.H., and Pollock B.G. Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs Aging 18 (2001) 355-368
58. Starkstein S.E., Mizrahi R., and Power B.D. Antidepressant therapy in post-stroke depression. Expert Opin. Pharmacother. 9 (2008) 1291-1298
59. Steffens D.C., Pieper C.F., Bosworth H.B., Macfall J.R., Provenzale J.M., Payne M.E., Carroll B.J., George L.K., and Krishnan K.R. Biological and social predictors of long-term geriatric depression outcome. Int. Psychogeriatr. 17 (2005) 41-56
60. Steffens D.C., Chung H., Krishnan K.R., Longstreth Jr. W.T., Carlson M., and Burke G.L. Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 39 (2008) 857-862
61. Steffens D.C., Taylor W.D., Mcquoid D.R., and Krishnan K.R. Short/long heterozygotes at 5HTTLPR and white matter lesions in geriatric depression. Int. J. Geriatr. Psychiatry 23 (2008) 244-248
62. Wendland J.R., Martin B.J., Kruse M.R., Lesch K.P., and Murphy D.L. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol. Psychiatry 11 (2006) 224-226
63. Williams R.B., Marchuk D.A., Gadde K.M., Barefoot J.C., Grichnik K., Helms M.J., Kuhn C.M., Lewis J.G., Schanberg S.M., Stafford-Smith M., Suarez E.C., Clary G.L., Svenson I.K., and Siegler I.C. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 28 (2003) 533-541
64. Wolf P.A., D'agostino R.B., Belanger A.J., and Kannel W.B. Probability of stroke: a risk profile from the Framingham Study. Stroke 22 (1991) 312-318
65. Zalsman G., Huang Y.Y., Oquendo M.A., Burke A.K., Hu X.Z., Brent D.A., Ellis S.P., Goldman D., and Mann J.J. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am. J. Psychiatry 163 (2006) 1588-1593